About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Designed to Protect More NVAF Patients from Stroke
By
Boston Scientific
By
Boston Scientific
461 views
June 20, 2023
See how the WATCHMAN FLX Implant is enabling more patients to leave OACs behind for life.
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
03:37
Boston Scientific
WATCHMAN: The Referring Process
Feat.
T. Diaz Balderrama,
R. Shah
05:09
Boston Scientific
WATCHMAN: An Alternative to OACs
Feat.
T. Diaz Balderrama,
R. Shah
01:44
Boston Scientific
Patient outcomes after receiving the WATCHMAN Implant
Feat.
T. Diaz Balderrama,
T. Randle,
R. Shah
01:27
Boston Scientific
Referring patients for the WATCHMAN Implant
Feat.
T. Diaz Balderrama,
T. Randle,
R. Shah
02:18
Boston Scientific
Freedom from OACs
Feat.
T. Diaz Balderrama,
T. Randle,
R. Shah
01:28
Boston Scientific
Protect your patients: Stroke risk reduction without the risks of OA…
Feat.
T. Diaz Balderrama,
T. Randle,
R. Shah
01:27
Boston Scientific
Proven Clinical Outcomes
Feat.
T. Diaz Balderrama,
T. Randle,
R. Shah
01:57
Boston Scientific
Identifying eligible patients for the WATCHMAN Implant
Feat.
T. Diaz Balderrama,
T. Randle,
R. Shah
01:01
Boston Scientific
Patient Screening & Criteria
04:24
Boston Scientific
Proven Stroke Protection Without Lifelong OAC Bleed Risk
31
Boston Scientific
Clinically Proven to Safely & Effectively Reduce NVAF Stroke Risk
31
Boston Scientific
Most Studied & Implanted LAAC Device
31
Boston Scientific
Proven Safety & Advanced Procedural Performance
31
Boston Scientific
Advancing Safety & Simplicity in LAAC - See the Difference
31
Boston Scientific
Proven to Reduce NVAF Stroke Risk for Life
31
Boston Scientific
Clinically Proven Safe Outcomes - PINNACLE FLX Clinical Trial Data
31
Boston Scientific
Advancing Safety In LAAC
31
Boston Scientific
Designed to Protect a Broad Range of Patients
31
Boston Scientific
Patient Eligibility Criteria
25:21
Congenital and Structural Interventions
LAA Closure for Atrial Fibrillation using Occlusion Device
Feat.
H. Sievert
31
Boston Scientific
Designed to Protect a Broad Range of Patients
31
Boston Scientific
Patient Eligibility Criteria
31
Boston Scientific
Clinically Proven to Safely & Effectively Reduce NVAF Stroke Risk
31
Boston Scientific
Advancing Safety & Simplicity in LAAC - See the Difference
31
Boston Scientific
Proven to Reduce NVAF Stroke Risk for Life
31
Boston Scientific
Clinically Proven Safe Outcomes - PINNACLE FLX Clinical Trial Data
31
Boston Scientific
Most Studied & Implanted LAAC Device
31
Boston Scientific
Proven Safety & Advanced Procedural Performance
03:46
Boston Scientific
WATCHMAN FLX™ Pro 40mm Device Overview with Dr.Nielsen-Kudsk
Feat.
J. Erik Nielsen-Kudsk
08:15
Georgia Heart Institute
Interview with Dr. Christopher Ellis: Left Atrial Appendage Manageme…
Feat.
D. Weisman,
C. Ellis
31
Boston Scientific
Advancing Safety In LAAC
18:26
Stanford Medicine
When Is LAA Closure Device an Option?
Feat.
C. Liu
14:16
Penn Medicine Heart and Vascular Center
Stroke Prevention in Atrial Fibrillation
Feat.
D. Goldberg
14:47
ACC 2023 Conference Coverage
ACC 2023: Can LAAC Be Considered a True Alternative to OAC?
Feat.
A. Natale
15:41
Scripps Health
Left Atrial Appendage: Correlating Anatomy, Imaging and Intervention
Feat.
D. Shook
14:23
The Texas Heart Institute
Atrial Fibrillation: New Treatments
Feat.
J. Cozart
16:28
Piedmont Heart Institute Napa Valley Cardiology Conference
The Stroke Prevention War: DOAC vs Warfarin vs LAA Device Closure
Feat.
T. Deering
08:49
University of Miami
A Revolutionary Approach to Left Atrial Appendage Closure - LAMINAR …
Feat.
S. Kar
20:15
Cardiology Fiesta 2017
The Guidelines: Current Recommendations for TAVR, Left Atrial Append…
Feat.
S. Bailey
